OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
0.00
0.00%
0.007 / 0.0231 (10000 x 10000)
6 Heddon Street
London, ENG W1B 4BT
United Kingdom
6 Heddon Street
London, ENG W1B 4BT
United Kingdom
MD, MBA
15 Westferry Circus
London, ENG E14 4HD
United Kingdom
HSBC Building, 885 West Georgia Street,
Suite 1480, Box 1078
Vancouver, BC V6C 3E8
Canada
The Broadgate Tower, 20 Primrose Street
London, ENG EC2A 2EW
United Kingdom
20 Primrose Street
London, ENG EC2A 2EW
United Kingdom
The Company is a preclinical biotechnology company focused on the development of innovative biological interventions (namely gene therapies) which are aimed at tackling the effects of ageing, potentially slowing or halting the ageing process and so reducing the incidence of age-related diseases and thereby increasing health span. The Company is seeking to develop treatments that can be applied to both humans and dogs.
A serviced lab is rented in Belgium.